(Q44142656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Highly efficient inhibition of human immunodeficiency virus type 1 reverse transcriptase by aptamers functionalized gold nanoparticles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Huan-Tsung Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Han-Jia Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

Yen-Chun Shiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Chung-Mao Ou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Shih-Ju Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ting-Yu Ou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

2756-2764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

21 January 2018

How does HIV cause AIDS?

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Replication of human immunodeficiency virus type 1 from entry to exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Human immunodeficiency virus reverse transcriptase and protease sequence database

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Novel therapies based on mechanisms of HIV-1 cell entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Drug combinations for HIV: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Molecular basis of human immunodeficiency virus drug resistance: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Oligomeric nucleic acids as antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Polyvalent DNA nanoparticle conjugates stabilize nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Bioconjugated nanoparticles for DNA protection from cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Therapeutic applications of DNA and RNA aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

A novel thrombin binding aptamer containing a G-LNA residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Conformation and thermostability of oligonucleotide d(GGTTGGTGTGGTTGG) containing thiophosphoryl internucleotide bonds at different positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Solid-state probe based electrochemical aptasensor for cocaine: a potentially convenient, sensitive, repeatable, and integrated sensing platform for drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer modules as sensors and detectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

G-Quadruplex-based DNAzyme for colorimetric detection of cocaine: using magnetic nanoparticles as the separation and amplification element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-nanoparticle assembly for logic-based detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Targeting cancer cells with nucleic acid aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-conjugated nanomaterials and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Colorimetric detection of platelet-derived growth factors through competitive interactions between proteins and functional gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Highly efficient control of thrombin activity by multivalent nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

A new approach to amplified telomerase detection with polyvalent oligonucleotide nanoparticle conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-based silver nanoparticles used for intracellular protein imaging and single nanoparticle spectral analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Anionic conjugated polymer with aptamer-functionalized silica nanoparticle for label-free naked-eye detection of lysozyme in protein mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-based PDMS-gold nanoparticle composite as a platform for visual detection of biomolecules with silver enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer conjugated magnetic nanoparticles as nanosurgeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Nanotechnology and HIV: potential applications for treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Nanomedicine applications towards the cure of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorus-containing dendrimers bearing galbeta1cer analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Inhibition of HIV fusion with multivalent gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Bioconjugated gold nanodots and nanoparticles for protein assays based on photoluminescence quenching.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Cell surface receptors, virus entry and tropism of primate lentiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Novel FRET-based assay to detect reverse transcriptase activity using modified dUTP analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

DNA vaccination and gene therapy: optimization and delivery for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Molecular crowding effects on structure and stability of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33403A

21 January 2018

Identifiers

DOI

10.1039/C3NR33403A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23429884%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference